eIF6 is potential diagnostic and prognostic biomarker that associated with 18 F-FDG PET/CT features and immune signatures in esophageal carcinoma.

Yan GaoLingling YuanJing ZengFuyan LiXiaohui LiFan TanXusheng LiuHuabing WanXueyan KuiXiaoyu LiuChangbin KeZhi-Jun Pei

Published in: Journal of translational medicine (2022)

Our study suggested that eIF6 might serve as a potential prognostic biomarker associated with metabolic variability and immune gene signatures in ESCA tumor microenvironment.

Keyphrases

genome wide
copy number
dna methylation